The most common mistake people make when searching for a weight-loss program at this scale is treating it like a short-term fix. Losing 50-plus pounds takes months, not weeks, and the biggest error is signing up for something that costs too much to sustain or ships medication from a pharmacy you can’t identify. The programs below are ranked for that specific situation: significant weight to lose, cash or insurance budget to manage, and a need for something that can actually run long enough to matter.
1. HealthRX
Start with the price. Compounded semaglutide from $99 per month, compounded tirzepatide from $149. Those numbers are genuinely low compared to most telehealth competitors, not a teaser rate that jumps after month one.
The pharmacy behind HealthRX’s medications is Manifest Pharmacy in Greer, South Carolina. It’s a 503A-accredited compounding pharmacy operating under USP-797 standards, with lot tracking from production through delivery. That detail matters because a lot of GLP-1 telehealth brands don’t name their compounding source at all. HealthRX also carries LegitScript certification (certificate 50087439), which is a real, independently verifiable credential.
Practically, the flow works like this: online health assessment, physician review within roughly 24 hours, overnight shipping to any of all 50 states at no added cost. Once-weekly injection. No contracts mentioned, no buried fees.
The clinical trial data HealthRX references, and these are not the brand’s own studies, shows tirzepatide producing around 21% body weight reduction over 72 weeks in SURMOUNT-1, and semaglutide around 15% over 68 weeks in STEP 1. These are compounded medications, not FDA-approved brand products, and that distinction is worth understanding before you start.
For someone with a lot of weight to lose and a limited budget, the combination of price, named pharmacy, verified credentials, and fast delivery puts this first.
2. FormBlends
FormBlends runs a similar telehealth-plus-compounded-GLP-1 model, but it distinguishes itself in a specific and verifiable way: it publishes per-product purity testing. We’re talking HPLC purity percentages, mass spectrometry identity confirmation, endotoxin and sterility results, with actual numbers attached. Most GLP-1 telehealth brands don’t do this.
The trade-off is price. Semaglutide comes in at roughly $299 per vial, tirzepatide at roughly $349. That’s higher than HealthRX’s entry-level pricing, which is why it ranks second here rather than first. Shipping reaches 47 states, not all 50.
Where FormBlends earns real consideration: if you want independent lab documentation on what’s in the vial, or if you’re also interested in peptides for recovery, cognition, or longevity, FormBlends carries a broader catalog under the same physician oversight model. Most GLP-1-only platforms don’t offer that. Dispensed through an FDA-registered 503A compounding pharmacy, with clinician oversight throughout.
Pick HealthRX if price and 50-state access are the priorities. Pick FormBlends if you want published purity data or plan to use additional peptide protocols alongside your GLP-1.
3. Mochi Health
The clinicians at Mochi hold board certification in obesity medicine, not general practice credentials. That specificity is meaningful when you’re managing a longer weight-loss arc. Compounded semaglutide runs about $99 per month and tirzepatide about $199, with more monitoring built in than some budget-tier competitors. Good option if you want clinical depth at a moderate price.
4. Ro Body
Ro‘s membership starts at $39 for the first month, then roughly $74 to $149 per month afterward, with medications billed separately. The prior-authorization team is a concrete benefit if you’re trying to get branded medication covered by insurance. Ro handles a lot of that paperwork in-house. For someone with employer insurance and a significant weight goal, the insurance navigation alone can make the difference.
5. Form Health
Premium tier. Around $299 per month, plus labs and medication costs on top. You get a physician and a registered dietitian working together, which is a different level of ongoing support than most telehealth options. If you have the budget and want structured, professional accountability across a multi-month plan, Form Health is one of the more thorough options available.
6. Henry Meds
Henry Meds runs cash-pay compounded GLP-1s at roughly $179 to $249 for the first month, with fast shipping, often 24 to 72 hours. The monitoring layer is thinner than what Mochi or Form Health provide. Good fit for someone who wants straightforward access and quick delivery without a heavy coaching layer.
7. Found
The platform fee runs about $99 per month, with medications billed on top of that. Coaching is included. The model works best for people who want some behavioral support alongside medication rather than medication alone.
8. Hims & Hers
After the Novo Nordisk settlement in March 2026, Hims & Hers moved away from compounded GLP-1s. Branded Wegovy runs about $299 per month through the platform, Zepbound around $399, and oral options around $249. With insurance and a manufacturer savings card, some people get to near-zero cost. Worth checking if you have good insurance coverage.
9. PlushCare
PlushCare’s membership is about $19.99 per month, with branded medications and insurance accepted. Same-day visits are available. For someone who wants a lower-friction way into a physician consultation and plans to run things through insurance, the low monthly fee makes it easy to start without a large commitment.
A Note Before You Choose
These programs all involve prescription medications, compounded or branded, and none of them replace a conversation with a doctor who knows your full health history. Compounded GLP-1s are not FDA-approved finished products, and the regulatory environment around them changed significantly in early 2026, so check current availability before committing to any plan.
Common Questions
Does losing 50-plus pounds take long enough that program cost becomes a bigger factor than for smaller goals?
Yes, and it’s one of the most practical considerations here. At 0.5 to 1 pound per week on GLP-1 therapy, a 50-pound goal runs roughly 12 to 24 months. A $99 monthly program costs $1,200 to $2,400 over that window. A $299 option runs $3,600 to $7,200. The math matters before you commit.
Is HealthRX’s compounded tirzepatide the same thing as Zepbound?
No. Compounded tirzepatide uses the same active molecule but is mixed at a 503A pharmacy, not manufactured by Eli Lilly. It is not FDA-approved as a finished drug product. HealthRX sources from Manifest Pharmacy in South Carolina. The clinical trial results cited (SURMOUNT-1) were conducted using Lilly’s branded product, not compounded versions.
Which of these programs includes a registered dietitian, not just a health coach?
Form Health is the only program on this list that explicitly pairs a physician with a registered dietitian as part of the standard plan. Mochi Health and Found include coaching, but the credentials of those coaches vary. If dietitian access is important to your plan, Form Health is the one to check first, at around $299 per month before medication costs.
After the 2026 Novo Nordisk settlement, can I still get compounded semaglutide anywhere on this list?
The regulatory picture shifted in early 2026. As of the information available here, HealthRX, FormBlends, Mochi Health, Henry Meds, and Found were still operating compounded GLP-1 programs, while Hims & Hers moved to branded products only. Availability can change quickly, so confirm directly with any platform before signing up.
If I have employer insurance, which program is most likely to actually reduce my out-of-pocket cost on branded medication?
Ro Body has a dedicated prior-authorization team that handles insurance paperwork in-house, which is a concrete structural advantage over most of the other platforms here. PlushCare also accepts insurance. For someone whose employer plan covers obesity medications, either of those two is worth checking before defaulting to a cash-pay compounded option.
Sources
- FDA: compounding oversight and 2026 warning letters to telehealth firms (FDA.gov)
- SURMOUNT-1 trial: tirzepatide efficacy data (NEJM, 2022)
- STEP 1 trial: semaglutide efficacy data (NEJM, 2021)
- LegitScript pharmacy certification database (LegitScript.com)
- Novo Nordisk compounding settlement announcement, March 2026 (public press release)
- Individual brand pricing pages (Hims & Hers, Ro, Mochi Health, Form Health, PlushCare, Found, Henry Meds, public 2025-2026)
